Identification and quantification of the main active anticancer alkaloids from the root of Glaucium flavum.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3876061)

Published in Int J Mol Sci on December 02, 2013

Authors

Lamine Bournine1, Sihem Bensalem, Jean-Noël Wauters, Mokrane Iguer-Ouada, Fadila Maiza-Benabdesselam, Fatiha Bedjou, Vincent Castronovo, Akeila Bellahcène, Monique Tits, Michel Frédérich

Author Affiliations

1: Plant Biotechnology and Ethnobotany Laboratory, Faculty of Natural Sciences and Life, University of Bejaia, Targa Ouzemour, 06000 Bejaia, Algeria. M.Frederich@ulg.ac.be.

Articles by these authors

Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer (2008) 3.04

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther (2002) 2.83

Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies. Hepatology (2013) 2.10

A six-gene signature predicting breast cancer lung metastasis. Cancer Res (2008) 2.09

Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene (2002) 2.02

Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Int J Cancer (2008) 1.93

Potential antimalarial activity of indole alkaloids. Trans R Soc Trop Med Hyg (2007) 1.73

Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB J (2005) 1.70

Discovery of a natural thiamine adenine nucleotide. Nat Chem Biol (2007) 1.64

Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells. Prostate (2012) 1.54

Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate (2002) 1.48

Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circ Res (2007) 1.46

Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation. Biochim Biophys Acta (2007) 1.43

Antimalarial compounds isolated from plants used in traditional medicine. J Pharm Pharmacol (2009) 1.42

Galectin-3 and cancer (Review). Int J Oncol (2004) 1.37

Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis (2007) 1.35

In vitro antiplasmodial activity of plants used in Benin in traditional medicine to treat malaria. J Ethnopharmacol (2009) 1.32

Expression of galectins in cancer: a critical review. Glycoconj J (2004) 1.28

Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene (2004) 1.26

Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells. Gastroenterology (2010) 1.22

Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. Am J Pathol (2004) 1.22

Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Lab Invest (2003) 1.21

NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa. Phytochem Anal (2004) 1.19

A HPTLC densitometric determination of flavonoids from Passiflora alata, P. edulis, P. incarnata and P. caerulea and comparison with HPLC method. Phytochem Anal (2004) 1.16

A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. Cancer Res (2007) 1.15

Effects of prodelphinidins isolated from Ribes nigrum on chondrocyte metabolism and COX activity. Naunyn Schmiedebergs Arch Pharmacol (2002) 1.13

Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting. Int J Cancer (2010) 1.11

Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer. Cancer Res (2009) 1.11

Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum (2008) 1.09

Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma. J Proteome Res (2011) 1.08

Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis. J Natl Cancer Inst (2011) 1.07

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood (2006) 1.04

Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. Int J Cancer (2008) 1.03

Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase. Bone (2010) 1.01

Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Res (2011) 1.00

About the toxicity of some Strychnos species and their alkaloids. Toxicon (2004) 0.99

Molecular mechanism underlying anti-inflammatory and anti-allergic activities of phytochemicals: an update. Molecules (2012) 0.98

Galectin-1 in melanoma biology and related neo-angiogenesis processes. J Invest Dermatol (2012) 0.96

Inhibitory effects of proanthocyanidins from Ribes nigrum leaves on carrageenin acute inflammatory reactions induced in rats. BMC Pharmacol (2004) 0.95

Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression. J Biol Chem (2007) 0.95

In vitro antiplasmodial activity of Tithonia diversifolia and identification of its main active constituent: tagitinin C. Planta Med (2002) 0.95

Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition. Biochem J (2004) 0.94

Histone deacetylases: anti-angiogenic targets in cancer therapy. Curr Cancer Drug Targets (2010) 0.94

Revealing the anti-tumoral effect of Algerian Glaucium flavum roots against human cancer cells. Phytomedicine (2013) 0.91

Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness. Int J Cancer (2006) 0.89

Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. Eur Urol (2006) 0.89

[Histone deacetylases: a new class of efficient anti-tumor drugs]. Med Sci (Paris) (2008) 0.88

The anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2. PLoS One (2013) 0.88

Isolation and pharmacological activity of phenylpropanoid esters from Marrubium vulgare. J Ethnopharmacol (2002) 0.88

Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model. Int J Cancer (2010) 0.88

LC/MS/NMR analysis of isomeric divanilloylquinic acids from the root bark of Fagara zanthoxyloides Lam. Phytochemistry (2004) 0.88

Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus. Am J Surg Pathol (2006) 0.87

Myoferlin is a key regulator of EGFR activity in breast cancer. Cancer Res (2013) 0.87

Five labdane diterpenoids from the seeds of Aframomum zambesiacum. Phytochemistry (2006) 0.86

Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C. J Ethnopharmacol (2012) 0.85

Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases. Anticancer Res (2012) 0.85

Metallothionein-dependent up-regulation of TGF-β2 participates in the remodelling of the myxomatous mitral valve. Cardiovasc Res (2011) 0.85

p53-dependent downregulation of metastasis-associated laminin receptor. Oncogene (2002) 0.84

Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies. Expert Rev Proteomics (2007) 0.84

Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation. Blood (2010) 0.84

Antioxidant and antiradical activities of Manihot esculenta Crantz (Euphorbiaceae) leaves and other selected tropical green vegetables investigated on lipoperoxidation and phorbol-12-myristate-13-acetate (PMA) activated monocytes. Nutrients (2011) 0.84

Selected protein monitoring in histological sections by targeted MALDI-FTICR in-source decay imaging. Anal Chem (2013) 0.84

Sparc-like protein 1 is a new marker of human glioma progression. J Proteome Res (2012) 0.84

Metabolomic investigation of the ethnopharmacological use of Artemisia afra with NMR spectroscopy and multivariate data analysis. J Ethnopharmacol (2010) 0.83

A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer. PLoS One (2013) 0.83

The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells. Angiogenesis (2012) 0.82

Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells. Neoplasia (2008) 0.82

Antiplasmodial activity of alkaloids from various strychnos species. J Nat Prod (2002) 0.82

Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis. J Proteome Res (2012) 0.82